|
NDC00019-5505-10
|
6505-01-303-8964
|
Ioxaglate Meglumine And Ioxaglat |
Mallinckrodt Inc
|
|
Quote
|
|
HEXABRIX
|
6505-01-303-8964
|
Ioxaglate Meglumine And Ioxaglat |
Mallinckrodt Inc
|
|
Quote
|
|
A89D103
|
6505-01-303-8964
|
Ioxaglate Meglumine And Ioxaglat |
Department of the Army
|
|
Quote
|
|
5505-102
|
6505-01-303-8964
|
Ioxaglate Meglumine And Ioxaglat |
Mallinckrodt Inc
|
|
Quote
|
|
PIPRACIL
|
6505-01-304-0788
|
Usp Piperacillin Sodium |
American Cyanamid Co
|
|
Quote
|
|
NDC00206-3882-28
|
6505-01-304-0788
|
Usp Piperacillin Sodium |
American Cyanamid Co
|
|
Quote
|
|
NDC63323-0381-20
|
6505-01-304-0788
|
Usp Piperacillin Sodium |
American Pharmaceutical Partners
|
|
Quote
|
|
4A8931
|
6505-01-304-1007
|
Anticoagulant Citrate Phosphate |
Abbott Laboratories
|
|
Quote
|
|
A89F024
|
6505-01-304-1007
|
Anticoagulant Citrate Phosphate |
Department of the Army
|
|
Quote
|
|
NDC00074-1967-04
|
6505-01-304-1007
|
Anticoagulant Citrate Phosphate |
Abbott Laboratories
|
|
Quote
|
|
NDC00074-1967-04
|
6505-01-304-1007
|
Anticoagulant Citrate Phosphate |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00065-0647-05
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Veterans Health
|
|
Quote
|
|
TOBRADEX
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
|
TOBRADEX EYE DROPS
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0647-05
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0647-05
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Cardinal Health 100 Inc
|
|
Quote
|
|
TOBRADEX
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Aah Pharmaceuticals Ltd
|
|
Quote
|
|
TOB0013S
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Aah Pharmaceuticals Ltd
|
|
Quote
|
|
PL00649/0119
|
6505-01-304-1008
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories Uk Ltd
|
|
Quote
|
|
NDC00182-0703-01
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Goldline Laboratories
|
|
Quote
|
|
NDC00603-4783-21
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00182-0703-89
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Ivax
|
|
Quote
|
|
NDC00904-0644-60
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC58177-0005-04
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Ethex Corp
|
|
Quote
|
|
NDC00185-1235-01
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Eon Labs Inc.
|
|
Quote
|
|
NDC00677-0486-01
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC49483-0222-10
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Time-cap Labs Inc
|
|
Quote
|
|
NDC00781-2786-01
|
6505-01-304-1014
|
Nitroglycerin Extended-release C |
Geneva Pharmaceuticals Inc
|
|
Quote
|
|
NDC58177-0005-03
|
6505-01-304-1016
|
Nitroglycerin Extended-release C |
Ethex Corp
|
|
Quote
|
|
NDC00781-2786-60
|
6505-01-304-1016
|
Nitroglycerin Extended-release C |
Sandoz Inc.
|
|
Quote
|
|
NDC00904-0643-52
|
6505-01-304-1017
|
Nitroglycerin Extended-release C |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00364-0174-06
|
6505-01-304-1017
|
Nitroglycerin Extended-release C |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC00781-2718-60
|
6505-01-304-1017
|
Nitroglycerin Extended-release C |
Sandoz Inc.
|
|
Quote
|
|
NDC00904-0643-50
|
6505-01-304-1017
|
Nitroglycerin Extended-release C |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00182-0702-01
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Goldline Laboratories
|
|
Quote
|
|
NDC00603-4782-21
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00182-0702-89
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Ivax
|
|
Quote
|
|
NDC00904-0643-60
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC58177-0004-04
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Ethex Corp
|
|
Quote
|
|
NDC00781-2718-01
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Sandoz Inc.
|
|
Quote
|
|
NDC00482-1025-01
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Kenwood Laboratories
|
|
Quote
|
|
NDC00185-5174-01
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Eon Labs Inc.
|
|
Quote
|
|
NDC00677-0485-01
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC49483-0221-10
|
6505-01-304-1018
|
Nitroglycerin Extended-release C |
Time-cap Labs Inc
|
|
Quote
|
|
NDC00364-2389-05
|
6505-01-304-1651
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2390-06
|
6505-01-304-1652
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2391-06
|
6505-01-304-1653
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
OCL SOLUTION
|
6505-01-304-2159
|
Colonic Lavage Oral Solution |
Abbott Laboratories Inc.
|
|
Quote
|
|
A89E047
|
6505-01-304-2159
|
Colonic Lavage Oral Solution |
Department of the Army
|
|
Quote
|
|
NDC00074-9099-16
|
6505-01-304-2159
|
Colonic Lavage Oral Solution |
Abbott Laboratories Inc.
|
|
Quote
|
|
ADRIAMYCIN PF5
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Action Business Corp
|
|
Quote
|
|
NDC00013-1166-83
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Erbamont Inc
|
|
Quote
|
|
NDC00703-5040-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Sicor Pharmaceuticals Sales Inc
|
|
Quote
|
|
A1166-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00074-1166-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC55390-0246-10
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Mova Pharmaceutical Corp
|
|
Quote
|
|
NDC55390-0248-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Mova Pharmaceutical Corp
|
|
Quote
|
|
NDC55390-0236-10
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC55390-0238-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
2G3504
|
6505-01-304-4964
|
Usp Cefriaxone Injection |
Baxter Healthcare Corporation
|
|
Quote
|
|
A89F002
|
6505-01-304-4968
|
Usp Ascorbic Acid Injection |
Department of the Army
|
|
Quote
|
|
CEVALIN
|
6505-01-304-4968
|
Usp Ascorbic Acid Injection |
Lilly Eli and Co Inc
|
|
Quote
|
|
NDC00002-1677-25
|
6505-01-304-4968
|
Usp Ascorbic Acid Injection |
Lilly Eli and Co Inc
|
|
Quote
|
|
F89F309
|
6505-01-304-4969
|
Modifie Docusate Sodium Solution |
Air Force Medical Logistics Office
|
|
Quote
|
|
NDC00536-0590-85
|
6505-01-304-4969
|
Modifie Docusate Sodium Solution |
Rugby Group Inc
|
|
Quote
|
|
6020590
|
6505-01-304-4969
|
Modifie Docusate Sodium Solution |
Rugby Group Inc
|
|
Quote
|
|
A89F015
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Department of the Army
|
|
Quote
|
|
BREVIBLOC
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
NDC10019-0015-71
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
BREVIBLOC INJECTION
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
NDC00590-0015-71
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
NDC00364-2389-06
|
6505-01-304-6412
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2390-05
|
6505-01-304-6413
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7216
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0180-03
|
6505-01-304-7216
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7217
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0180-04
|
6505-01-304-7217
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7218
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0181-04
|
6505-01-304-7218
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
H10298
|
6505-01-304-7218
|
Octreotide Acetate Injection |
Barenboim Cia Ltda
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7220
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0181-03
|
6505-01-304-7220
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
0332-59
|
6505-01-304-9017
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0332-79
|
6505-01-304-9017
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
MAALOX PLUS SUSP
|
6505-01-304-9017
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
BETAGAN
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Allergan Inc
|
|
Quote
|
|
BETAGAN C CAP QD
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Allergan Inc
|
|
Quote
|
|
NDC11980-0252-65
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Allergan Inc
|
|
Quote
|
|
NDC24208-0505-05
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Bausch & Lomb Pharmaceuticals
|
|
Quote
|
|
NDC00364-3039-53
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Schein Pharmaceutical Inc
|
|
Quote
|
